ARA-290 10 mg
$75.00
Non-erythropoietic EPO-derived peptide selectively activating the Innate Repair Receptor. ≥98% purity, 10 mg lyophilized. For laboratory research only.
- 🔒 Secure Checkout
- ↩️ 30-Day Easy Returns
- ⭐ Premium Quality Guaranteed
🛍️ Frequently Bought Together
🔒Secure Checkout
🚚Fast Shipping
↩️Easy Returns
✅Quality Guaranteed
Description
ARA-290 (Cibinetide) is a synthetic 11-amino acid peptide derived from the structure of Erythropoietin (EPO), engineered to selectively activate the Innate Repair Receptor (IRR).
Research Profile
Unlike native EPO, ARA-290 lacks erythropoietic activity and instead selectively engages the EPO receptor/CD131 heterodimer complex (Innate Repair Receptor). Published research has documented its cytoprotective, anti-inflammatory, and tissue-reparative signaling through STAT3, NF-κB inhibition, and Akt/eNOS pathways, without stimulating red blood cell production. Clinical trials have investigated its neuroprotective and metabolic applications.
IRR AgonistNon-Erythropoietic10 mg Lyophilized≥98% Purity
This product is not a drug, dietary supplement, or food. It is not intended to diagnose, treat, cure, or prevent any disease. No claims are made regarding biological activity, outcomes, or effects. By purchasing this product, the buyer acknowledges that it is for research use only and agrees to handle, store, and dispose of it in accordance with all applicable laws and regulations.
Reviews
There are no reviews yet.